Understanding how estradiol affects risk-taking behavior in females
Official title: Investigation of the neurobiological mechanisms underlying estradiol-mediated risk aversion in females
Funded at University of Texas at Austin · NIH-10811683 · Data updated 2026-11-12
This study is looking at how the hormone estradiol affects decision-making and risk-taking in females, using rats to see how drug use might change these behaviors, with the hope of improving treatment options for women dealing with addiction.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas at Austin NIH-funded |
| Lab location | 1 site (Austin, United States) |
| Project start | April 1, 2023 |
| Project end | January 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $547,810 |
| NIH project number | 5R01DA055676-02 |
| Project ID | NIH-10811683 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research would be females who have a history of substance use or are at risk of developing substance use disorders.
✕Less likely to help
Patients who are male or those who do not have a history of substance use may not receive direct benefits from this research.
What this research studies
This research investigates the neurobiological mechanisms that influence decision-making and risk aversion in females, particularly focusing on the hormone estradiol. Using a rat model, the study aims to explore how chronic drug exposure alters the neural pathways that govern risk-taking behavior, which may differ significantly from males. By examining these mechanisms, the research seeks to identify how substance use impacts decision-making processes in females, potentially leading to better treatment strategies for addiction. The findings could help bridge the gap between animal studies and clinical applications, enhancing our understanding of female-specific responses to drugs.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment approaches for women struggling with substance use disorders by tailoring interventions based on hormonal influences on decision-making.
How similar studies have gone: While there has been significant research on risk-taking behavior in males, this approach focusing specifically on females and the role of estradiol is relatively novel and has not been extensively tested.
Where this research is happening
-
University of Texas at Austin
Austin, United States Active
Researchers
- Principal investigator: Orsini, Caitlin Anne — University of Texas at Austin
- Study coordinator: Orsini, Caitlin Anne
Related research
Other NIH-funded projects on the same topics.
-
Translating new nerve grafts to clinical use
Aims to bring advanced nerve graft technology that uses PEG-fusion and localized immunosuppression to patients with nerve gaps.
-
GABA-A receptor gating mechanisms and how drugs affect them
Researchers are studying how GABA-A receptor gates work and how medicines can modulate them to help people with epilepsy, Alzheimer's-related symptoms, and other brain disorders.
-
Nanoparticles that calm inflammation after artery procedures
A new nanoparticle inspired by dying cells is being tested to reduce inflammation after artery procedures and help PAD patients heal better.
-
Silent speech interface using a wearable tongue tracker to help people after laryngectomy communicate
A wearable system with tongue sensors and intraoral components aims to let people without a vocal cord use natural-sounding speech in daily life.
-
Understanding and reversing abnormal brain activity in Alzheimer's disease
Aims to understand how unusual brain activity contributes to Alzheimer’s and test ways to reverse it to help people with the condition.
-
CFDE Cloud Workspace to help researchers share and analyze data
A cloud-based workspace will let a wide range of researchers import, integrate, and analyze data from CFDE and other sources using familiar tools and workflows.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.